Very High-Power Ablation for Contiguous Pulmonary Vein Isolation: Results From the Randomized POWER PLUS Trial.
O'Neill L, El Haddad M, Berte B, Kobza R, Hilfiker G, Scherr D, Manninger M, Wijnmaalen AP, Trines SA, Wielandts JY, Gillis K, Lycke M, De Becker B, Tavernier R, Le Polain De Waroux JB, Knecht S, Duytschaever M.
O'Neill L, et al. Among authors: de becker b.
JACC Clin Electrophysiol. 2023 Apr;9(4):511-522. doi: 10.1016/j.jacep.2022.10.039. Epub 2023 Jan 18.
JACC Clin Electrophysiol. 2023.
PMID: 36752467
Free article.
Clinical Trial.
Prospective endpoints were procedural efficiency (procedure time and first-pass isolation), safety (including esophageal endoscopic evaluation), and 6-month effectiveness using repetitive Holter monitoring. ...CONCLUSIONS: Contiguous ablation using very high-power, short-d …
Prospective endpoints were procedural efficiency (procedure time and first-pass isolation), safety (including esophageal endoscopic e …